Year |
Citation |
Score |
2007 |
Ramos SJ, Hardison JL, Stiles LN, Lane TE, Walsh CM. Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system. Autoimmunity. 40: 54-65. PMID 17364498 DOI: 10.1080/08916930600996700 |
0.596 |
|
2006 |
Stiles LN, Hardison JL, Schaumburg CS, Whitman LM, Lane TE. T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection. Journal of Immunology (Baltimore, Md. : 1950). 177: 8372-80. PMID 17142734 DOI: 10.4049/Jimmunol.177.12.8372 |
0.568 |
|
2006 |
Hardison JL, Kuziel WA, Manning JE, Lane TE. Chemokine CC receptor 2 is important for acute control of cardiac parasitism but does not contribute to cardiac inflammation after infection with Trypanosoma cruzi. The Journal of Infectious Diseases. 193: 1584-8. PMID 16652288 DOI: 10.1086/503812 |
0.645 |
|
2006 |
Lane TE, Hardison JL, Walsh KB. Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system Current Topics in Microbiology and Immunology. 303: 1-27. PMID 16570854 DOI: 10.1007/978-3-540-33397-5_1 |
0.597 |
|
2006 |
Hardison JL, Wrightsman RA, Carpenter PM, Kuziel WA, Lane TE, Manning JE. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infection and Immunity. 74: 135-43. PMID 16368966 DOI: 10.1128/Iai.74.1.135-143.2006 |
0.683 |
|
2006 |
Hardison JL, Wrightsman RA, Carpenter PM, Lane TE, Manning JE. The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi. Infection and Immunity. 74: 125-34. PMID 16368965 DOI: 10.1128/Iai.74.1.125-134.2006 |
0.686 |
|
2006 |
Hardison JL, Nistor G, Gonzalez R, Keirstead HS, Lane TE. Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response. Experimental Neurology. 197: 420-9. PMID 16297915 DOI: 10.1016/J.Expneurol.2005.10.016 |
0.512 |
|
2006 |
Gonzalez R, Hardison JL, Glaser J, Liu MT, Lane TE, Keirstead HS. The chemokine CXCL10 as a therapeutic target in animal models of neuroinflammatory disease Letters in Drug Design and Discovery. 3: 683-688. DOI: 10.2174/157018006778631839 |
0.319 |
|
2004 |
Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, Lane TE. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 172: 4018-25. PMID 15034013 DOI: 10.4049/Jimmunol.172.7.4018 |
0.606 |
|
2004 |
Trifilo MJ, Montalto-Morrison C, Stiles LN, Hurst KR, Hardison JL, Manning JE, Masters PS, Lane TE. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. Journal of Virology. 78: 585-94. PMID 14694090 DOI: 10.1128/Jvi.78.2.585-594.2004 |
0.641 |
|
Show low-probability matches. |